• YM 58483 (BTP2): Applied SOCE Blockade in Fibrosis Research

  2026-06-20

  YM 58483 (BTP2) delivers highly selective inhibition of CRAC and TRP channels, enabling precise dissection of calcium-dependent signaling in immune and fibrosis models. Its integration into workflows targeting the ORAI2/JNK/NFAT1 axis sets a new standard for experimental control in both in vitro and in vivo studies.

• AEBSF.HCl: Optimizing Protease Inhibition in Cell Death Assa

  2026-06-19

  AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) delivers robust, irreversible serine protease inhibition across amyloid, necroptosis, and cell lysis models. This guide translates cutting-edge reference discoveries into actionable workflows, troubleshooting, and performance-driven insights for high-impact research.

• Kupffer Cell Plasticity in Liver Metastasis: Insights from L

  2026-06-19

  This study dissects the origins and adaptability of liver metastasis-associated macrophages, highlighting the phenotypic and functional plasticity of Kupffer cells. The findings suggest that targeting both monocyte recruitment and macrophage proliferation may be necessary to reprogram the immunosuppressive microenvironment in hepatic metastases.

• Indazole/Indole-Based Glucagon Receptor Antagonists: Synthes

  2026-06-18

  This study reports a novel series of indazole- and indole-based glucagon receptor antagonists (GRAs), designed to address unmet therapeutic needs in type 2 diabetes. The work details innovative synthetic methods, robust in vitro and in vivo evaluation, and structure–activity relationship (SAR) insights, contributing to the field of small-molecule antidiabetic drug discovery.

• Canonical Anti-Apoptotic Role of MCL-1 in Breast Cancer Surv

  2026-06-18

  This article reviews a pivotal study demonstrating that breast cancer cell survival is critically dependent on the canonical anti-apoptotic function of MCL-1. By dissecting genetic and pharmacological evidence, the findings clarify the molecular basis for targeting MCL-1 in cancer research and inform experimental strategies for apoptosis induction.

• Sulfo-Cy3 Azide: Benchmark Bioconjugation Reagent for Click

  2026-06-17

  Sulfo-Cy3 azide is a highly water-soluble, photostable bioconjugation reagent engineered for Click Chemistry fluorescent labeling. Its superior performance in aqueous labeling of alkyne-modified oligonucleotides and proteins is supported by quantitative benchmarks and translational neurodevelopmental research.

• HyperFusion High-Fidelity DNA Polymerase: Precision for Chal

  2026-06-17

  HyperFusion™ high-fidelity DNA polymerase redefines PCR workflows by combining ultra-high fidelity, rapid extension, and exceptional tolerance to inhibitors. This enzyme empowers researchers to tackle GC-rich, long, or complex templates with minimal optimization—making it a best-in-class choice for neurogenetics, cloning, and high-throughput sequencing applications.

• Degarelix Acetate: Aggregation Science and Assay Optimizatio

  2026-06-16

  Explore the latest insights into Degarelix acetate as a GnRH receptor antagonist, with a unique focus on peptide aggregation behavior and its practical impact on hormone secretion inhibition assays. Uncover how advanced structural understanding informs robust protocol design.

• PPT (Propyl Pyrazole Triol): Applied Workflows for ERα Resea

  2026-06-16

  PPT (Propyl Pyrazole Triol) empowers researchers to dissect ERα-mediated gene expression with exceptional selectivity, driving advances in cancer and hormone signaling studies. This guide translates the latest biomarker insights and workflow optimizations into actionable protocols, troubleshooting tips, and comparative advantages for estrogen receptor research.

• CAY10499: Inhibitor of Human Hormone Sensitive Lipase in Lip

  2026-06-15

  CAY10499 stands apart as a selective, potent inhibitor of human hormone sensitive lipase and monoglyceride lipase, enabling precise dissection of lipid signaling and immunometabolic pathways. This article unpacks advanced workflows and troubleshooting strategies to drive reproducible results in lipid metabolism and tumor microenvironment research.

• CmOGD2-Mediated Ferroptosis and Iron Uptake in Citrus Canker

  2026-06-15

  This reference study uncovers how the Citron gene CmOGD2 enhances resistance to citrus canker by promoting iron uptake and reactive oxygen species (ROS) accumulation, triggering ferroptosis-like cell death. These findings offer mechanistic insight into plant-pathogen interactions and highlight parallels with ferroptosis research in mammalian systems.

• LINC01278 Suppresses Uveal Melanoma via mTOR Pathway Inhibit

  2026-06-14

  The referenced study identifies LINC01278 as a long noncoding RNA that acts as a tumor suppressor in uveal melanoma by inducing autophagy through mTOR pathway suppression. This mechanistic insight provides a potential new target for therapeutic strategies in UM and demonstrates the utility of mTOR modulators in dissecting pathway-specific effects on tumor biology.

• AP1903: Precision FKBP-Binding Ligand for Conditional Cell A

  2026-06-13

  AP1903 empowers researchers with nanomolar, tunable control over FKBP fusion protein activity for apoptosis pathway research and conditional cell ablation. Its robust compatibility with multiplexed workflows and potent, specific action make it indispensable for precise signal modulation in advanced cell-based assays.

• Comparative In Vitro Activity of Sisomicin and Tobramycin

  2026-06-12

  This article examines the pivotal study by Stewart and Bodey, which assessed the in vitro efficacy of sisomicin relative to established aminoglycoside antibiotics, including tobramycin, against a broad spectrum of clinical Gram-negative and Gram-positive isolates. The findings inform antibiotic selection and resistance research protocols in microbiology.

• BMS 309403: FABP4 Inhibitor for Atherosclerosis Research

  2026-06-12

  BMS 309403, a potent and selective FABP4 inhibitor, enables precise interrogation of lipid metabolism and inflammatory processes in macrophages and atherosclerosis models. Using validated protocols and troubleshooting tips, researchers can optimize workflows to dissect the CaN/FoxO1/FABP4 pathway and its therapeutic implications in cardiovascular and metabolic disease.

14919 records 1/995 page Next 12345 下5页 Last page